GRNA
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
GRNA
Delisted
GRNA was delisted on the 21st of July, 2023.
70 hedge funds and large institutions have $163M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+16
Holders Change %
+29.63%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
17
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HCM
Highbridge Capital Management
New York
|
+$6.98M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$6.56M |
| 3 |
OPU
Omni Partners US
Irvine,
California
|
+$6.21M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$5.78M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$4.48M |
Top Sellers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$30.7M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$13M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$4.66M |
| 4 |
Goldman Sachs
New York
|
-$3.28M |
| 5 |
CAC
Cowen and Company
New York
|
-$2.94M |